Physician profile

Thomas Pennix

Houston, TX

NPI 1184203515

$448.11

in general payments reported to CMS, 2019-2025

4 companies · $214 in 2025

The $214 reported for 2025 was more than what a typical provider received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$448.11

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $276.37 2024-2025 Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered
Inari Medical, INC. $106.32 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Stryker Corporation $41.55 2025 Artix Mt
Terumo Medical Corporation $23.87 2025 Angio-Seal

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas Pennix

$448.11

in general payments reported 2019-2025

Years
2023-2025
Top company
Boston Scientific Corporation
Context
The $214 reported for 2025 was more than what a typical provider received nationally.

https://glasscript.com/doctor/11565341/thomas-pennix

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.